🟢 Neumora Therapeutics is trading 5% up in pre-market

Neumora Therapeutics is trading 5% up at $0.50 in pre-market, but the reason for the increase remains unclear.

• No fresh company-specific announcement clearly explains the move; the surfaced CEO appointment was announced in August, not October 12.
• Major U.S. indices were nearly flat in the supplied market context, while a report said XBI fell 0.4%.
• No pre-market volume or activity data was available.